Andrea de Bartolomeis

Affiliations: 
Neuroscience University School of Medicine of Naples Federico II Italy 
Area:
Schizophrenia, psychosis, antipsychotics, synapse, Homer
Google:
"Andrea de Bartolomeis"
Bio:

Andrea de Bartolomeis MD PhD Biosketch

Andrea de Bartolomeis M.D., Ph.D. is Associate Professor of Psychiatry, director of the Section of Psychiatry and Treatment Resistant Psychosis program at Department of Neuroscience, University School of Medicine of Napoli Federico II,
He is also the Director of the Residency program in Psychiatry

Andrea de Bartolomeis received his medical degree and his residency training in psychiatry at the University of Naples Federico II, Italy.

(Show more)

Mean distance: 17.93 (cluster 19)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Polese D, Fornaro M, Palermo M, et al. (2019) Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis. Frontiers in Psychiatry. 10: 210
Fornaro M, Solmi M, Stubbs B, et al. (2019) Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. 1-10
de Bartolomeis A, Iasevoli F, Marmo F, et al. (2018) Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Fornaro M, Anastasia A, Novello S, et al. (2018) Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis. Bipolar Disorders
de Bartolomeis A, Buonaguro EF, Latte G, et al. (2017) Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes. Frontiers in Behavioral Neuroscience. 11: 240
D'Urso G, Dell'Osso B, Rossi R, et al. (2017) Clinical predictors of acute response to transcranial direct current stimulation (tDCS) in major depression. Journal of Affective Disorders. 219: 25-30
Orsolini L, Tomasetti C, Valchera A, et al. (2016) Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine. Cns & Neurological Disorders Drug Targets
De Berardis D, Fornaro M, Orsolini L, et al. (2016) Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice. Cns Spectrums. 1-6
Buonaguro EF, Tomasetti C, Chiodini P, et al. (2016) Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia. Journal of Psychopharmacology (Oxford, England)
Palazzo E, Luongo L, Guida F, et al. (2016) D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. Amino Acids
See more...